Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines

Manufacturing procedures for cellular therapies are continuously improved with particular emphasis on product safety. We previously developed a dendritic cell (DC) cancer vaccine technology platform that uses clinical grade lipopolysaccharide (LPS) and interferon (IFN)-y for the maturation of monocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Dohnal, Alexander Michael, Graffi, Sebastian, Witt, Volker, Eichstill, Christina, Wagner, Dagmar, Ul-Haq, Sidrah, Wimmer, Doris, Felzmann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823041/
https://www.ncbi.nlm.nih.gov/pubmed/18363835
http://dx.doi.org/10.1111/j.1582-4934.2008.00304.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823041/
https://www.ncbi.nlm.nih.gov/pubmed/18363835
http://dx.doi.org/10.1111/j.1582-4934.2008.00304.x

Ejemplares similares